文献速递前列腺癌

根治性前列腺切除术后放疗时机对健康相关生活质量的影响

Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life.
PubMed 文献 · J Urol · 2021-06-29

本研究纳入4,511例根治性前列腺切除术后患者,经1:4倾向评分匹配分析1,599例(早期放疗307例,延迟放疗1,292例)。结果显示延迟放疗组在12和24个月随访时总体健康相关生活质量评分显著更高,且尿失禁和勃起功能结局更优。多因素分析表明延迟放疗与12和24个月时更优的总体健康相关生活质量独立相关。

要点

  • 延迟放疗组12和24个月总体生活质量评分显著高于早期放疗组。
  • 早期放疗组尿失禁评分更高、勃起功能评分更低。
  • 根治性前列腺切除至放疗间隔越长,短期总体生活质量越好。

核心结论

  • 与早期放疗相比,延迟放疗可获得更好的短期健康相关生活质量。
  • 根治性前列腺切除与放疗之间较长的时间间隔预测更好的短期总体健康相关生活质量。

研究设计与样本

  • 回顾性分析4,511例根治性前列腺切除术后患者,纳入标准为≥pT3、ISUP分级≥4或手术切缘阳性。
  • 采用1:4倾向评分匹配分析1,599例患者,其中早期放疗(术后≤6个月)307例,延迟放疗(术后>6个月)1,292例。
  • 主要终点为基于EORTC QLQ-C30的总体健康相关生活质量,功能结局采用ICIQ-SF和IIEF-5问卷评估。

主要发现

  • 中位随访38个月,12个月时延迟放疗组总体生活质量评分52.7 vs 早期放疗组35.5(p=0.001),24个月时45.8 vs 37.3(p=0.026)。
  • 12个月时早期放疗组ICIQ-SF评分8.5 vs 延迟放疗组6.1(p=0.001),24个月时8.4 vs 7.3(p=0.038)。
  • 12个月时早期放疗组IIEF-5评分1.8 vs 延迟放疗组4.2(p=0.001),24个月时2.2 vs 4.4(p=0.005)。
  • 多因素分析显示延迟放疗与12个月(OR 0.59,95%CI 0.37-0.94,p=0.027)和24个月(OR 0.64,95%CI 0.39-0.99,p=0.043)更优的总体健康相关生活质量相关。
  • 根治性前列腺切除与放疗间隔较长与总体健康相关生活质量改善相关(OR 1.09,95%CI 1.038-1.143,p<0.001)。

临床怎么用

  • 对于根治性前列腺切除术后低前列腺特异性抗原复发风险的患者,可考虑延迟放疗以改善短期生活质量。
  • 与患者沟通放疗时机时,应权衡早期放疗对尿失禁和勃起功能的短期负面影响。

局限性

  • 本研究为回顾性分析,可能存在选择偏倚。
  • 中位随访仅38个月,缺乏长期生活质量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The optimal timing of radiotherapy (RT) after radical prostatectomy (RP) remains controversial with unknown impact on health-related quality of life (HRQOL). We aimed to compare the influence of early RT (eRT) and deferred RT (dRT) on HRQOL. MATERIALS AND METHODS: A total of 4,511 patients were analyzed. Inclusion criteria encompassed: ≥pT3, International Society of Urological Pathology grade ≥4, or positive surgical margin. A 1:4 propensity score-matched-analysis of 1,599 patients was conducted (307: eRT, ≤6 months after RP; 1,292: dRT, >6 months after RP). Primary end point was general HRQOL (based on European Organisation for Research and Treatment of Cancer QLQ-C30). Pearson correlation and binary logistic regression models were used to estimate the impact of timing of RT on HRQOL. Functional outcome was assessed using the International Consultation on Incontinence Questionnaire, short form (ICIQ-SF) and International Index of Erectile Function (IIEF-5) questionnaires. RESULTS: Median followup was 38 months. At 12 months and 24 months followup, general HRQOL scores were significantly higher for dRT (52.7 vs 35.5; p=0.001; 45.8 vs 37.3; p=0.026). ICIQ-SF scores were higher (8.5 vs 6.1; p=0.001; 8.4 vs 7.3; p=0.038), and IIEF-5 scores were lower (1.8 vs 4.2; p=0.001; 2.2 vs 4.4; p=0.005) for eRT at 12 months and 24 months. On multivariate-analysis, dRT was associated with superior general HRQOL at 12 months (OR 0.59, 95% CI 0.37-0.94, p=0.027) and 24 months (OR 0.64, 95% CI 0.39-0.99, p=0.043), respectively. A longer time interval between RP and RT was associated with improved general HRQOL (OR 1.09, 95% CI 1.038-1.143; p <0.001). CONCLUSIONS: dRT yields improved short-term HRQOL compared to eRT. Since longer time intervals between RP and RT predict better short-term HRQOL, our data provide further support for the concept of deferred RT at low prostate specific antigen recurrence.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Westhofen T, Buchner A, Schlenker B, et al. Timing of Radiotherapy after Radical Prostatectomy: Effects on Health-Related Quality of Life. J Urol. 2021. PMID: 34184923. doi:10.1097/JU.0000000000001930

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。